Acusphere Inc (ACUS)
Acusphere, Inc. is a specialty pharmaceutical company focused on developing and commercializing cardiovascular medicines. Its main product is Imagify, a perflubutane polymer microspheres injectable suspension used in myocardial perfusion imaging and in the detection of coronary artery disease. The company was previously known as Polymers For Medicine, Inc. and adopted the Acusphere name in March 2004. Founded in 1993, Acusphere is based in Watertown, Massachusetts. Its common stock is listed on OTC Markets under the symbol ACUS.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ACUS
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.004 K
|
—
|
—
|
—
|
—
|
—
|
—
|
